SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Ethema Health Corp. – ‘8-K’ for 2/1/24

On:  Wednesday, 2/7/24, at 4:45pm ET   ·   For:  2/1/24   ·   Accession #:  1903596-24-61   ·   File #:  0-15078

Previous ‘8-K’:  ‘8-K/A’ on 12/22/23 for 10/16/23   ·   Latest ‘8-K’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/07/24  Ethema Health Corp.               8-K:1,9     2/01/24   13:15M                                    SEC Filing Solut… LLC/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     23K 
 2: EX-10.01    Material Contract                                   HTML     13K 
 3: EX-10.02    Material Contract                                   HTML      6K 
 4: EX-10.03    Material Contract                                   HTML      9K 
 8: R1          Cover                                               HTML     39K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
13: XML         XBRL Instance -- grst_8k_htm                         XML     15K 
 9: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 6: EX-101.LAB  XBRL Labels -- grst-20240201_lab                     XML     96K 
 7: EX-101.PRE  XBRL Presentations -- grst-20240201_pre              XML     64K 
 5: EX-101.SCH  XBRL Schema -- grst-20240201                         XSD     12K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    35K 
12: ZIP         XBRL Zipped Folder -- 0001903596-24-000061-xbrl      Zip     16K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX: 
 i false  i 0000792935  i false  i false  i false  i false 0000792935 2024-02-01 2024-02-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM  i 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  i February 1, 2024

 

 i ETHEMA HEALTH CORPORATION

(Exact name of registrant as specified in its charter)

 

 i Colorado  i 000-15078  i 84-1227328

(State or other jurisdiction of

incorporation or organization)

(Commission File Number)

(IRS Employer

Identification No.)

 

 i 950 Evernia Street,  i West Palm Beach,  i Florida  i 33401
(Address of principal executive offices)

 

( i 416)  i 500-0020
(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[ ]   Written communications pursuant to Rule 425 under the Securities Act

 

[ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

[ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

ITEM 1.01    ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

Testing 123, LLC (“Testing”)

 

On February 1, 2024 Ethema Health Corporation, American Treatment Holdings Inc, and Evernia Health Center LLC (the “Company” or “Companies”) entered into a revolving line of credit agreement (“ Agreement”) with Testing. The term of the Agreement is two years and the maximum amount that may be drawn down is $1,000,000.00. The foregoing summary of the terms and conditions of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Revolving Line of Credit Agreement, The Loan Agreement and the Security Agreement by and between the Company and Testing, dated January 31, 2024 which are filed as Exhibits 10.01, 10.02 and 10.03 hereto, respectively.

 

Item9.01 Financial Statements and Exhibits.

 

(d)       Exhibits

 

Exhibit No. Description

10.01       Revolving Line of Credit Agreement dated January 31, 2024

10.02       Loan Agreement dated January 31, 2024

10.03       Security Agreement dated January 31, 2024

 

 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 7, 2024

 

By: /s/ Shawn E. Leon

Name: Shawn E. Leon

Title: CEO

 

 

 


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on:2/7/24None on these Dates
For Period end:2/1/24
1/31/24
 List all Filings 
Top
Filing Submission 0001903596-24-000061   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 8:04:19.1pm ET